Back to dashboard
CommercialCoverageMedium impact

08.02.27, Tarlatamab-dlle (Imdelltra™) for intravenous use

Independence Blue Cross·Oncology, Hematology·Pharmacy
Effective date
Apr 21, 2025
We identified it
Jun 19, 2026
Days to comply
—

Summary

A new pharmacy policy for Tarlatamab-dlle (Imdelltra™) intravenous medication has been established. This is a brand new coverage policy that will take effect on April 21, 2025, providing guidance on coverage criteria and billing requirements for this specialty medication.

Action Required

Action needed
Before April 21, 2025: Billing team should monitor for additional policy details and coding guidance for Tarlatamab-dlle (Imdelltra™) as this new specialty medication becomes available. Review the full policy document when published to understand coverage criteria, prior authorization requirements, and applicable HCPCS J-codes.

Related policy hubs